The enantioselective teratogenicity of 2-n-propyl-4-pentynoic acid (4-yn-VPA) is due to stereoselective intrinsic activity and not differences in pharmacokinetics
- 30 April 1992
- journal article
- research article
- Published by Elsevier in Toxicology Letters
- Vol. 60 (2) , 145-153
- https://doi.org/10.1016/0378-4274(92)90269-p
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Zu den strukturellen Grundlagen der teratogenen Wirkung des Antiepileptikums Valproinsäure (VPA)The Science of Nature, 1989
- Asymmetric synthesis and enantioselective teratogenicity of 2-n-propyl-4-pentenoic acid (4-en-VPA), an active metabolite of the anticonvulsant drug, valproic acidToxicology Letters, 1989
- Enantioselective Aspects of Drug Action and Disposition: Therapeutic PitfallsJournal of Pharmaceutical Sciences, 1989
- Valproic Acid Prenatal ExposureClinical Pediatrics, 1989
- Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acidThe Journal of Pediatrics, 1986
- Possible Valproate TeratogenicityArchives of Neurology, 1985
- VALPROATE AND BIRTH DEFECTSThe Lancet, 1983
- VALPROIC ACID AND SPINA BIFIDAThe Lancet, 1982
- A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrationsLife Sciences, 1981
- Teratogenicity of valproic acid: In vivo and in vitro investigationsTeratogenesis, Carcinogenesis, and Mutagenesis, 1981